ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT AUGUST 2025

Zinzino group revenue increased with a total of 38 %, compared with the previous year.

 

The revenue in August for Zinzino's sales markets increased by 46 % and amounted to SEK 243.6 (167.0) million. Faun Pharma's external sales decreased and amounted to SEK 3.3 (12.2) million. Overall, the Group increased revenues by 38 % to SEK 246.9 (179.2) million compared with the previous year.

Accumulated revenue for January – August 2025 increased by 55 % to SEK 2,028.7 (1,309.9) million.

 

Revenues were distributed as follows:

Regions,MSEK	25-Aug	24-Aug	Change	YTD 2025	YTD 2024	Change
The Nordics	26.3	24.0	10%	208.2	188.6	10%
Central Europe	72.2	45.7	58%	563.9	345.7	63%
East Europe	28.8	31.0	-7%	246.8	251.6	-2%
South & West Europe	40.9	32.9	24%	350.0	226.5	55%
The Baltics	9.6	6.7	43%	76.3	62.2	23%
North America	41.1	15.6	163%	341.3	113.7	200%
Asia-Pacific	22.6	9.8	131%	191.6	38.0	404%
Africa	2.1	1.3	62%	14.1	9.7	45%
Zinzino	243.6	167.0	46%	1,992.2	1,236.0	61%
Faun Pharma	3.3	12.2	-73%	36.5	73.9	-51%
Zinzino Group	246.9	179.2	38%	2,028.7	1,309.9	55%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge:
marketing@zinzino.com

 

Certified Adviser:
DNB Carnegie Investment Bank AB (publ.)